PCE Pancreatic Cancer Europe

Itinéraire Site Web Contacter l’organisation

PCE Pancreatic Cancer Europe Informations de contact, plan et itinéraire, formulaire de contact, heures d'ouverture, services, évaluations, photos, vidéos et annonces de PCE Pancreatic Cancer Europe, Organisation à but non lucratif, Square Ambiorix 10, Bruxelles / Brussel.

European multi-stakeholder platform that brings together experts, academics, physicians, politicians, patient groups, journalists and industry with a common interest and willingness to improve care for patients with pancreatic cancer

20/10/2026

Thank you to everyone who made PCE’s Brainstorming Meeting at UEG Week 2026 on 17 October a success!

The meeting brought valuable discussions on pancreatic cancer primary prevention and screening interventions.

A report sharing the key outcomes will be prepared in the coming weeks. Stay tuned!

UEG - United European Gastroenterology European Pancreatic Club - EPC Digestive Cancers Europe - for Patients

We’re pleased to bring the pancreatic cancer community’s voice to the new Patient Representatives Advisory Board (PRAB),...
20/10/2026

We’re pleased to bring the pancreatic cancer community’s voice to the new Patient Representatives Advisory Board (PRAB), launched by UEG - United European Gastroenterology on 18 October at UEG Week 2026 in Barcelona.

The board creates a dedicated platform for patient organisations to help shape UEG’s public affairs activities and wider work to improve digestive health across Europe. Launched during the Digestive Health Roundtable 2026, the initiative builds on a shared commitment to recognising patients as co-creators of research, policy and care.

Through our participation, Pancreatic Cancer Europe will bring the experiences and priorities of people affected by pancreatic cancer into these discussions, working alongside fellow patient organisations to identify shared challenges and advance common priorities.

Read more: https://pancreaticcancereurope.eu/news/pce-joins-uegs-new-patient-representatives-advisory-board/

18/10/2026

We’re at in Barcelona!

Come and meet the Pancreatic Cancer Europe team in the Community Area, Hall 6, and learn more about our work.

Don’t forget to take part in our Spot the Purple campaign, in collaboration with the European Pancreatic Club, for a chance to win some local goodies!

We look forward to seeing you!

UEG - United European Gastroenterology European Pancreatic Club - EPC

18/10/2026
18/10/2026
Are you here at UEG Week 2026?Come and say hello to the Pancreatic Cancer Europe team in the Community Area, Hall 6!Whil...
18/10/2026

Are you here at UEG Week 2026?

Come and say hello to the Pancreatic Cancer Europe team in the Community Area, Hall 6!

While you’re here, join our Spot the Purple campaign, in collaboration with the European Pancreatic Club - EPC, for a chance to win some local goodies.

Spot something purple, snap a creative photo and help us create a digital mosaic for Pancreatic Cancer Awareness Month. We’d love to see you so stop by for a chat!

UEG - United European Gastroenterology

Our Brainstorming Meeting on Pancreatic Cancer Primary Prevention and Screening Interventions has kicked off at   in Bar...
17/10/2026

Our Brainstorming Meeting on Pancreatic Cancer Primary Prevention and Screening Interventions has kicked off at in Barcelona!

Organised in collaboration with the European Pancreatic Club - EPC and UEG - United European Gastroenterology, the meeting brings together leading experts, researchers and patient advocates to explore ways to strengthen pancreatic cancer prevention and early detection.

Todays discussions cover the epidemiological landscape, emerging risk factors, lifestyle interventions and strategies for primary prevention. We look forward to a productive day of exchanging knowledge and ideas to help advance pancreatic cancer prevention and improve patient outcomes.

We are very happy to welcome the news that the European Medicines Agency (EMA) has recommended authorisation of Rasonque...
16/10/2026

We are very happy to welcome the news that the European Medicines Agency (EMA) has recommended authorisation of Rasonque (daraxonrasib), developed by Medicines, for previously treated adults with metastatic pancreatic cancer.

At Pancreatic Cancer Europe, we are committed to improving treatment options and access to care for people affected by pancreatic cancer. We will continue to follow regulatory developments closely and share reliable information with our community across Europe.

Read more on our website: https://pancreaticcancereurope.eu/news/ema-recommends-authorisation-of-daraxonrasib-for-metastatic-pancreatic-cancer/

EMA Recommends Authorisation of Daraxonrasib for Metastatic Pancreatic Cancer

Pancreatic Cancer Europe (PCE) was pleased to take part in the 3rd Botton Champalimaud Foundation / Fundação Champalimau...
16/10/2026

Pancreatic Cancer Europe (PCE) was pleased to take part in the 3rd Botton Champalimaud Foundation / Fundação Champalimaud International Pancreatic Cancer Conference, held in Lisbon on 8–10 October.

Our PancreOS Project Officer, Raquel Benítez Dorta, represented PCE, exchanging insights with European pancreatic cancer networks, discussing shared challenges and exploring opportunities to strengthen collaboration and accelerate pancreatic cancer research across Europe.

Thank you to the organisers and participants for the valuable discussions!

Adresse

Square Ambiorix 10
Brussels
1000

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque PCE Pancreatic Cancer Europe publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.

Contacter L’organisation

Envoyer un message à PCE Pancreatic Cancer Europe:

Partager